BREAKING NEWS
newsdailyFebruary 23, 2021
1000-3.jpeg

3min10

After a year that has darkened doorways across the U.S., the pandemic surpassed a milestone Monday that once seemed unimaginable, a stark confirmation of  the virus reach into all corners of the country and communities of every size and makeup.

“It’s very hard for me to imagine an American who doesn’t know someone who has died or have a family member who has died,” said Ali Mokdad, a professor of health metrics at the University of Washington in Seattle. “We haven’t really fully understood how bad it is, how devastating it is, for all of us.”

Experts warn that about 90,000 more deaths are likely in the next few months, despite a massive campaign to vaccinate people. Meanwhile, the nation’s trauma continues to accrue in a way unparalleled in recent American life, said Donna Schuurman of the Dougy Center for Grieving Children & Families in Portland, Oregon.

In recent weeks, virus deaths have fallen from more than 4,000 reported on some days in January to an average of fewer than 1,900 per day.

Still, at half a million, the toll recorded by Johns Hopkins University is already greater than the population of Miami or Kansas City, Missouri. It is roughly equal to the number of Americans killed in World War II, the Korean War and the Vietnam War combined. It is akin to a 9/11 every day for nearly six months.

“The people we lost were extraordinary,” President Joe Biden said Monday, urging Americans to remember the individual lives claimed by the virus, rather than be numbed by the enormity of the toll. “Just like that,” he said, “so many of them took their final breath alone in America.”–AP

 


newsdailyNovember 16, 2020
thumbs_b_c_5f9c20763ebfa7b4fa166fd8e4d3855c.jpg

5min20

The U.S company Moderna, which is working on Covid Vaccine,  said on Monday that its COVID-19 vaccine is proving to be highly effective in a major trial, the second dash of hope in the global race for a shot to tame a resurgent virus that is now killing more than 8,000 people a day worldwide.

The company said its vaccine appears to be 94.5% effective, according to preliminary data from Moderna’s ongoing study. A week ago, competitor Pfizer Inc. announced its own COVID-19 vaccine appeared similarly effective news that puts both companies on track to seek permission within weeks for emergency use in the U.S.

The results are “truly striking,” said Dr. Anthony Fauci, the U.S. government’s top infectious diseases expert. Earlier this year, Fauci said he would be happy with a COVID-19 vaccine that was 60% effective.

A vaccine can’t come fast enough, as virus cases topped 11 million in the U.S. over the weekend 1 million of them recorded in just the past week and governors and mayors are ratcheting up restrictions ahead of Thanksgiving. The pandemic has killed more than 1.3 million people worldwide, over 245,000 of them in the U.S.

Dr. Stephen Hoge, Moderna’s president, welcomed the “really important milestone” but said having similar results from two different companies is what’s most reassuring.

“That should give us all hope that actually a vaccine is going to be able to stop this pandemic and hopefully get us back to our lives,” Hoge told The Associated Press. He added: “It won’t be Moderna alone that solves this problem. It’s going to require many vaccines” to meet the global demand.

The National Institutes of Health helped create the vaccine Moderna is manufacturing, and NIH’s director, Dr. Francis Collins, said the exciting news from two companies “gives us a lot of confidence that we’re on the path towards having effective vaccines.”

But “we’re also at this really dark time,” he warned, saying people can’t let down their guard during the months it will take for doses of any vaccines cleared by the Food and Drug Administration to start reaching a large share of the population.

If the FDA allows emergency use of Moderna’s or Pfizer’s candidate, there will be limited, rationed supplies before the end of the year.

Both vaccines require people to get two shots, several weeks apart. U.S. officials said they hope to have about 20 million Moderna doses and another 20 million doses of the vaccine made by Pfizer and its German partner BioNTech to use in late December.

Moderna’s vaccine is being studied in 30,000 volunteers who received either the real thing or a dummy shot. On Sunday, an independent monitoring board examined 95 infections that were recorded after volunteers’ second dose, and they discovered all but five illnesses occurred in participants who got the placebo.

The study is continuing, and Moderna acknowledged the protection rate might change as more COVID-19 infections are detected. Also, it’s too soon to know how long protection lasts. Both cautions apply to Pfizer’s vaccine as well.–AP

 



About us

News Daily is a platform where news is collected from difference sources.News Daily offer latest news headlines on Electonic formate. You get all latest updates and notification on your device.


CONTACT US